Míriam Méndez

1.1k total citations
54 papers, 528 citations indexed

About

Míriam Méndez is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Míriam Méndez has authored 54 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Míriam Méndez's work include Lymphoma Diagnosis and Treatment (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer survivorship and care (7 papers). Míriam Méndez is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer survivorship and care (7 papers). Míriam Méndez collaborates with scholars based in Spain, United States and Colombia. Míriam Méndez's co-authors include Mariano Provencio, Ana Custodio, Félix Bonilla, Marta Rodríguez, Gemma Domínguez, Javier Silva, Vanesa García‐Barberán, Ana López‐Alfonso, Cristina Peña and María Torrente and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Míriam Méndez

50 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Míriam Méndez Spain 12 245 168 154 120 63 54 528
Andreas Weinhaeusel Austria 14 232 0.9× 93 0.6× 123 0.8× 94 0.8× 60 1.0× 31 507
Xiaoling Weng China 16 382 1.6× 160 1.0× 187 1.2× 91 0.8× 34 0.5× 31 696
Huan-Ming Hsu Taiwan 16 393 1.6× 172 1.0× 207 1.3× 73 0.6× 62 1.0× 32 718
Thomas A. Samuel United States 13 239 1.0× 163 1.0× 68 0.4× 167 1.4× 38 0.6× 30 567
Abul Usmani India 10 155 0.6× 210 1.3× 134 0.9× 86 0.7× 37 0.6× 21 484
Johannes Fritzmann Germany 13 392 1.6× 218 1.3× 154 1.0× 78 0.7× 59 0.9× 33 667
Shuqin Dai China 15 239 1.0× 198 1.2× 170 1.1× 138 1.1× 29 0.5× 40 575
Stephanie Needham United Kingdom 9 370 1.5× 87 0.5× 89 0.6× 57 0.5× 54 0.9× 12 620
Cinthya Sternberg Brazil 12 314 1.3× 215 1.3× 195 1.3× 165 1.4× 29 0.5× 28 656
Petra Martin Ireland 12 140 0.6× 201 1.2× 96 0.6× 161 1.3× 33 0.5× 32 448

Countries citing papers authored by Míriam Méndez

Since Specialization
Citations

This map shows the geographic impact of Míriam Méndez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Míriam Méndez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Míriam Méndez more than expected).

Fields of papers citing papers by Míriam Méndez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Míriam Méndez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Míriam Méndez. The network helps show where Míriam Méndez may publish in the future.

Co-authorship network of co-authors of Míriam Méndez

This figure shows the co-authorship network connecting the top 25 collaborators of Míriam Méndez. A scholar is included among the top collaborators of Míriam Méndez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Míriam Méndez. Míriam Méndez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calvo, Virginia, et al.. (2024). Quality of care assessment for non-small cell lung cancer patients: transforming routine care data into a continuous improvement system. Clinical & Translational Oncology. 27(3). 1047–1061. 1 indexed citations
2.
Méndez, Míriam, et al.. (2024). San Isidro, Sonsonate, El Salvador: Development of a Preclassic Settlement in Chronological and Geographic Context. Journal of Field Archaeology. 49(5). 371–390. 1 indexed citations
3.
Núñez, Beatriz, Juan Cristóbal Sánchez, Ana Royuela, et al.. (2023). Long‐term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population. Hematological Oncology. 41(3). 407–414. 2 indexed citations
4.
Sánchez‐Beato, Margarita, Míriam Méndez, M. Guirado, et al.. (2023). A genetic profiling guideline to support diagnosis and clinical management of lymphomas. Clinical & Translational Oncology. 26(5). 1043–1062. 7 indexed citations
5.
Majem, Margarita, R. de las Peñas, Juan Antonio Virizuela, et al.. (2022). SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2021). Clinical & Translational Oncology. 24(4). 712–723. 8 indexed citations
6.
7.
Torrente, María, Fernando Franco, Virginia Calvo, et al.. (2022). Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors. Frontiers in Cardiovascular Medicine. 9. 1062858–1062858. 9 indexed citations
8.
Torrente, María, Virginia Calvo, Ana Collazo, et al.. (2022). Risk factors for cardiovascular events in patients treated with immunotherapy.. Journal of Clinical Oncology. 40(16_suppl). e18736–e18736. 1 indexed citations
9.
Franco, Fernando, M. Guirado, Natividad Martínez-Banaclocha, et al.. (2021). Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel). Current Oncology. 28(2). 1249–1255. 1 indexed citations
10.
Mitroi, Cristina, et al.. (2021). 749P Cardiotoxicity in patients treated with PARP-inhibitors. Annals of Oncology. 32. S743–S743. 2 indexed citations
11.
Méndez, Míriam, Blanca Cantos, Juan Cristóbal Sánchez, et al.. (2021). Immunotherapy toxicity in patients over 65 years.. Journal of Clinical Oncology. 39(15_suppl). 12027–12027. 1 indexed citations
12.
Garcia, Daniel, J. Domínguez, Clara Salas, et al.. (2021). Checkpoint inhibitor-induced fulminant myocarditis, complete atrioventricular block and myasthenia gravis—a case report. Cardiovascular Diagnosis and Therapy. 11(4). 1013–1019. 20 indexed citations
13.
Méndez, Míriam, et al.. (2019). Cuestionario/guía para la evaluación de proyectos de investigación con datos por un CEI: (En cumplimiento del Reglamento Europeo 2016/679 de protección de datos y la Ley Orgánica 3/2018, de 5 de diciembre, de Protección de Datos Personales y garantía de los derechos digitales). 25–33. 1 indexed citations
14.
Méndez, Míriam, et al.. (2019). Evaluación de proyectos de investigación con tecnología Big Data por un Comité de Ética de la investigación. 349–393. 1 indexed citations
15.
Méndez, Míriam, et al.. (2019). La legitimación para el tratamiento de categorías especiales de datos con finalidades de investigación en el marco del Reglamento (UE) 2016/679 y de la Ley Orgánica 3/2018. 205–231.
16.
Méndez, Míriam, María Torrente, & Mariano Provencio. (2017). Follicular lymphomas and their transformation: Past and current research. Expert Review of Hematology. 10(6). 515–524. 9 indexed citations
17.
Franco, Fernando, Antonio Sánchez, Blanca Cantos, et al.. (2014). Does the presence of hepatitis virus B and C influence the evolution of diffuse large B-cell lymphoma?. Leukemia & lymphoma. 56(6). 1686–1690. 5 indexed citations
18.
19.
Méndez, Míriam, et al.. (2008). Botulismo del lactante. Anales de Pediatría. 68(5). 499–502. 5 indexed citations
20.
Méndez, Míriam, et al.. (1989). Prevalencia de marcadores serologicos de hepatitis virica en diversos grupos de poblacion del peru. 106(2). 127–138. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Weinhaeusel Breakdown of academic impact, for papers by Xiaoling Weng Breakdown of academic impact, for papers by Huan-Ming Hsu Breakdown of academic impact, for papers by Thomas A. Samuel Breakdown of academic impact, for papers by Abul Usmani Breakdown of academic impact, for papers by Johannes Fritzmann Breakdown of academic impact, for papers by Shuqin Dai Breakdown of academic impact, for papers by Stephanie Needham Breakdown of academic impact, for papers by Cinthya Sternberg Breakdown of academic impact, for papers by Petra Martin
Rankless by CCL
2026